Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 5, Issue 6, Pages 511-514
http://dx.doi.org/10.1155/1998/959750
Case Report

Recurrence of Intravenous Talc Granulomatosis following Single Lung Transplantation

Richard C Cook,1 Guy Fradet,1 John C English,2 John Soos,3 Nestor L Müller,4 Thomas P Connolly,1 and Robert D Levy1

1University of British Columbia Lung Transplant Program, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada
2Department of Pathology, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada
3Department of Psychology, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada
4Department of Radiology, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada

Copyright © 1998 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Advanced pulmonary disease is an unusual consequence of the intravenous injection of oral medications, usually developing over a period of several years. A number of patients with this condition have undergone lung transplantation for respiratory failure. However, a history of drug abuse is often considered to be a contraindication to transplantation in the context of limited donor resources. A patient with pulmonary talc granulomatosis secondary to intravenous methylphenidate injection who underwent successful lung transplantation and subsequently presented with recurrence of the underlying disease in the transplanted lung 18 months after transplantation is reported.